TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will release its financial results for first quarter 2022 on May 9, 2022; a press release with the financial report will be released after the market closes. The company will also host a conference call and webcast on the same day, scheduled to begin at 5 p.m. ET. The purpose of the event will be to discuss the company’s Q1 financial report; the call will also include a Q&A session. Those interested in participating on the call can dial 1-877-425-9470 in the United States or 1-201-389-0878 for international callers; all callers should use conference ID 13728738. Those planning to call are encouraged to dial in at least 10 minutes before the call to ensure participation. A playback of the will be available until June 9, 2022; those interested in accessing that should dial 1-844-512-2921 within the United States or 1-412-317-6671 internationally, and then enter replay pin number 13728738.
To view the webcast, visit https://ibn.fm/Td3Ej
To view the full press release, visit https://ibn.fm/n6zQG
About TRxADE Health Inc
TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug procurement marketplace serving more than 13,475 members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient-centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
